Isovue -370
Presence of Particulate Matter; fibers identified as cellulose and polyvinyl
Class I — High risk. Reasonable probability of serious harm or death.
Presence of Particulate Matter; fibers identified as cellulose and polyvinyl
Cause type: Particulate / foreign matter
Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.
Isovue -300 (Iopamidol) Injection 61% Prefilled, 10 x 100 mL Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany); NDC 0270-1315-67.
Compare with the code on your package — it is the most precise check available.
Drug: Iopamidol
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Isovue 300 Iopamidol NDC 00270-1315 |
612 mg/mL | Injection, Solution Intravascular |
Bracco Diagnostics Inc | Rx |
Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Presence of Particulate Matter; fibers identified as cellulose and polyvinyl
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Failed stability specifications:This recall has been initiated due to out of specification results for viscosity.
Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.
Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months.
Presence of Particulate Matter; fibers identified as cellulose and polyvinyl
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.